Product Images Aripiprazole
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 11 images provide visual information about the product associated with Aripiprazole NDC 17856-0570 by Atlantic Biologicals Corp., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
image 1 - 17856 0570 01
Aripiprazole Oral Solution is delivered at 5mg/5mL per cup. Dosage and indications are available in the package insert. Store the solution at room temperature, keeping it away from the children. The solution comes in a quantity of 72 cups and has an expiration date of 12109120. The product is distributed by AtlanticBiologicals Corp, Miami. To reorder, call 800.509.7592.*
17856 0570 02
This is a description of Aripiprazole Oral solution delivered at a concentration of 5mg/ml. The package insert indicates the indications and dosage schedule. The solution needs to be stored at controlled room temperature within 15-30°C (59-86°F), and kept away from children. The dosage is 5ml (17856-0570-02). This solution is manufactured by Unit Dose Solutions, distributed by Atlantic Biologicals Corp., and have a SIN of 01333301 RX, and GTIN of 0011785607024. The expiry date of the product is 09/12/21. Call 800.509.7592 for reorder.*
Structure - aripiprazole oral solution 1
Figure 1 - aripiprazole oral solution 2
This appears to be a figure caption from a research article showing the effects of other drugs on the pharmacokinetics of aripiprazole. The image seems to illustrate the change in relative bioavailability and maximum concentration caused by co-administration of different drugs. It is not possible to obtain a clear understanding of the entire analysis from this caption only.*
Figure 2 - aripiprazole oral solution 3
This appears to be a figure with the title "The effects of other drugs on dehydro-aripiprazole pharmacokinetics" and its content shows the impact of different drugs on Aripiprazole. The graph shows changes relative to the reference without an interacting drug and displays the effect on different parameters like Cmax and AUC. No detailed information is available.*
Figure 3 - aripiprazole oral solution 4
This text describes the effects of Aripiprazole on the pharmacokinetics of other drugs. Figure 3 is provided, which represents the relative change in the pharmacokinetics of different drugs when taking Aripiprazole compared to a reference state without taking any drugs. The scientific data table includes the names of the drugs and the changes in their effect while taking Aripiprazole.*
Figure 4 - aripiprazole oral solution 5
The given text contains a table or a figure named "Figure 4" that represents the effects of intrinsic factors on aripiprazole pharmacokinetics for special populations. The table presents changes in AUC R based on intrinsic factors such as poor vs. extensive metabolizers, gender, weight, hepatic impairment (normal vs. moderate vs. severe), and renal impairment (severe). Apart from this, no other information is available in the given text, so the description is not comprehensive enough to convey a meaningful understanding of the topic.*
Figure 5 - aripiprazole oral solution 6
Figure 6 - aripiprazole oral solution 7
Figure 7 - aripiprazole oral solution 8
Figure 8 - aripiprazole oral solution 9
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.